Raymond James & Associates lessened its stake in shares of Waters Co. (NYSE:WAT – Get Rating) by 15.6% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,477 shares of the medical instruments supplier’s stock after selling 2,497 shares during the quarter. Raymond James & Associates’ holdings in Waters were worth $3,632,000 at the end of the most recent reporting period.
Other institutional investors have also bought and sold shares of the company. EdgeRock Capital LLC acquired a new stake in shares of Waters during the third quarter worth approximately $27,000. Clear Street Markets LLC increased its holdings in Waters by 404.0% during the 2nd quarter. Clear Street Markets LLC now owns 126 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 101 shares in the last quarter. Allworth Financial LP raised its position in Waters by 48.4% in the 2nd quarter. Allworth Financial LP now owns 187 shares of the medical instruments supplier’s stock valued at $62,000 after purchasing an additional 61 shares during the last quarter. CX Institutional acquired a new position in Waters in the second quarter worth $64,000. Finally, C M Bidwell & Associates Ltd. bought a new stake in shares of Waters during the second quarter worth $90,000. Institutional investors and hedge funds own 88.58% of the company’s stock.
Insider Activity at Waters
In related news, Director Edward Conard sold 1,059 shares of the company’s stock in a transaction on Wednesday, November 30th. The shares were sold at an average price of $334.70, for a total value of $354,447.30. Following the completion of the sale, the director now owns 74,224 shares in the company, valued at approximately $24,842,772.80. The transaction was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 0.77% of the company’s stock.
Waters Stock Up 1.0 %
Waters (NYSE:WAT – Get Rating) last posted its earnings results on Tuesday, November 1st. The medical instruments supplier reported $2.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.57 by $0.07. The company had revenue of $708.56 million during the quarter, compared to analyst estimates of $680.30 million. Waters had a return on equity of 189.79% and a net margin of 23.63%. Equities research analysts expect that Waters Co. will post 11.92 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several research analysts recently issued reports on the stock. SVB Leerink upped their price target on shares of Waters from $320.00 to $352.00 and gave the stock a “market perform” rating in a research report on Friday, January 6th. Deutsche Bank Aktiengesellschaft began coverage on shares of Waters in a research report on Tuesday, December 13th. They set a “hold” rating and a $350.00 target price on the stock. StockNews.com started coverage on shares of Waters in a report on Wednesday, October 12th. They issued a “buy” rating for the company. Barclays reduced their price objective on Waters from $345.00 to $340.00 and set an “overweight” rating on the stock in a report on Thursday, October 6th. Finally, TheStreet raised Waters from a “c+” rating to a “b-” rating in a research note on Monday, November 7th. Six analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, Waters presently has an average rating of “Hold” and a consensus price target of $345.22.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
- Get a free copy of the StockNews.com research report on Waters (WAT)
- Exxon Mobil Stock: Within Striking Distance Of Buy Point
- High-Dividend-Yielding BHP Sees China Driving ’23 Growth
- Is Airbnb Setting Up To Rally 38%, As Analysts Are Forecasting?
- Does a Price Cut for Tesla Vehicles Mean the Same for TSLA Stock?
- Microsoft Layoffs Signal Layoffs for Other Tech Companies?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.